Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $15,823.89 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 15,363 shares of the company’s stock in a transaction that occurred on Wednesday, April 17th. The shares were purchased at an average cost of $1.03 per share, with a total value of $15,823.89. Following the completion of the purchase, the chief executive officer now owns 14,352,831 shares of the company’s stock, valued at approximately $14,783,415.93. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Retractable Technologies Price Performance

Shares of NYSE RVP opened at $1.06 on Friday. The company has a current ratio of 8.28, a quick ratio of 6.41 and a debt-to-equity ratio of 0.01. The business’s 50 day moving average price is $1.20 and its 200-day moving average price is $1.16. Retractable Technologies, Inc. has a fifty-two week low of $0.95 and a fifty-two week high of $1.87.

Institutional Investors Weigh In On Retractable Technologies

Several hedge funds and other institutional investors have recently modified their holdings of RVP. Cubist Systematic Strategies LLC purchased a new position in Retractable Technologies during the 2nd quarter worth $40,000. Royal Bank of Canada boosted its position in shares of Retractable Technologies by 29.7% in the 1st quarter. Royal Bank of Canada now owns 13,265 shares of the company’s stock worth $63,000 after purchasing an additional 3,037 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new stake in shares of Retractable Technologies in the 2nd quarter worth $54,000. Virtu Financial LLC acquired a new stake in shares of Retractable Technologies in the 2nd quarter worth $57,000. Finally, FMR LLC lifted its position in Retractable Technologies by 190.0% during the 2nd quarter. FMR LLC now owns 16,216 shares of the company’s stock worth $62,000 after acquiring an additional 10,625 shares during the period. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Retractable Technologies in a research note on Wednesday. They issued a “hold” rating for the company.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.